Electrical storm in patients with implantable cardioverter-defibrillators: Can it be forecast?

Texas Heart Institute Journal

Volumn 36, Issue 6, 2009, Pages 563-567

  Emkanjoo, Zahra ^a   Alihasani, Narges ^a   Alizadeh, Abolfath ^a   Tayyebi, Mohammad ^a   Bonakdar, Hamid ^a   Barakpour, Hamid ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antiarrhythmia agents; Arrhythmias, cardiac prevention control; Cardiac pacing, artificial; Defibrillators, implantable; Electric countershock; Electrical storm; Heart failure; Tachycardia, ventricular therapy; Ventricular dysfunction, left

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE ASSOCIATION; ELECTRICAL STORM; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTOR VARIABLE; PREVALENCE; PRIMARY PREVENTION; RETROSPECTIVE STUDY; SECONDARY PREVENTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 76149134344     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-83.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators [published erratum appears in N Engl J Med 2000;342(17):1300]. N Engl J Med 1999;341(25):1882-90.
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337 (22):1576-83.
4. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92(1):59-65.
5. Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R, et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996;93(4):753-62.
6. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32(7): 1909-15.
7. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001;103(16):2066-71.
8. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000;2(3):263-9.
9. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005; 7(2):184-92.
10. Endoh Y, Ohnishi S, Kasanuki H. Clinical significance of consecutive shocks in patients with left ventricular dysfunction treated with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999;22(1 Pt 2):187-91.
11. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007;4(11):1395-402.
12. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15(11):1265-70.
13. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000; 102(7):742-7.
14. Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W, et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2004;43(9):1715-20.
15. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101(11):1288-96.